Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Inclusion Criteria
CL425202 (UMLS CUI 2011AA)
age 60 Years to 75 Years
Item
age 60 Years to 75 Years
boolean
C0001779 (UMLS CUI 2011AA)
397669002 (SNOMED CT 2011_0131)
primary or secondary AML as defined by WHO or refractory anemia with excess of blasts (RAEB)
Item
primary or secondary AML as defined by WHO or refractory anemia with excess of blasts (RAEB)
boolean
CL414904 (UMLS CUI 2011AA)
C0023467 (UMLS CUI 2011AA)
91861009 (SNOMED CT 2011_0131)
10000880 (MedDRA 14.1)
C92.0 (ICD-10-CM Version 2010)
205.0 (ICD-9-CM Version 2011)
C0011900 (UMLS CUI 2011AA)
439401001 (SNOMED CT 2011_0131)
MTHU008876 (LOINC Version 232)
C0280449 (UMLS CUI 2011AA)
C1704788 (UMLS CUI 2011AA)
C0451584 (UMLS CUI 2011AA)
273931002 (SNOMED CT 2011_0131)
C0002894 (UMLS CUI 2011AA)
398623004 (SNOMED CT 2011_0131)
10038270 (MedDRA 14.1)
D46.20 (ICD-10-CM Version 2010)
First complete remission following one or two cycles of induction chemotherapy
Item
First complete remission following one or two cycles of induction chemotherapy
boolean
C0205435 (UMLS CUI 2011AA)
255216001 (SNOMED CT 2011_0131)
C0677874 (UMLS CUI 2011AA)
103338009 (SNOMED CT 2011_0131)
C0332282 (UMLS CUI 2011AA)
255260001 (SNOMED CT 2011_0131)
C0439596 (UMLS CUI 2011AA)
44180009 (SNOMED CT 2011_0131)
C0600558 (UMLS CUI 2011AA)
Chemotherapy was administered according to current participating cooperative group protocols
Item
Chemotherapy was administered according to current participating cooperative group protocols
boolean
C0392920 (UMLS CUI 2011AA)
150415003 (SNOMED CT 2011_0131)
C1521801 (UMLS CUI 2011AA)
C0680240 (UMLS CUI 2011AA)
C0679823 (UMLS CUI 2011AA)
PART (HL7 V3 2006_05)
CL415249 (UMLS CUI 2011AA)
RGRP (HL7 V3 2006_05)
C2348563 (UMLS CUI 2011AA)
Karnofsky score >= 70
Item
Karnofsky performance status (assessment scale)
boolean
C0206065 (UMLS CUI 2011AA)
273546003 (SNOMED CT 2011_0131)
Written informed consent
Item
Written informed consent
boolean
C0021430 (UMLS CUI 2011AA)
Item Group
Exclusion Criteria
CL425201 (UMLS CUI 2011AA)
AML FAB M3
Item
AML FAB M3
boolean
C0023467 (UMLS CUI 2011AA)
91861009 (SNOMED CT 2011_0131)
10000880 (MedDRA 14.1)
C92.0 (ICD-10-CM Version 2010)
205.0 (ICD-9-CM Version 2011)
C0457329 (UMLS CUI 2011AA)
278165002 (SNOMED CT 2011_0131)
HIV positivity
Item
HIV Seropositivity
boolean
C0019699 (UMLS CUI 2011AA)
165816005 (SNOMED CT 2011_0131)
10020188 (MedDRA 14.1)
Z21 (ICD-10-CM Version 2010)
Participation in another clinical trial without prior consent of the coordinating investigator, patients may exceptionally take part in a further study only if
Item
Participation in another clinical trial without prior consent of the coordinating investigator, patients may exceptionally take part in a further study only if
boolean
C0679823 (UMLS CUI 2011AA)
PART (HL7 V3 2006_05)
C0205394 (UMLS CUI 2011AA)
74964007 (SNOMED CT 2011_0131)
C0008976 (UMLS CUI 2011AA)
110465008 (SNOMED CT 2011_0131)
C0332197 (UMLS CUI 2011AA)
2667000 (SNOMED CT 2011_0131)
C1511481 (UMLS CUI 2011AA)
MTHU035862 (LOINC Version 232)
CL102947 (UMLS CUI 2011AA)
C1554961 (UMLS CUI 2011AA)
E (HL7 V3 2006_05)
The second study exclusively concerns induction therapy
Item
The second study exclusively concerns induction therapy
boolean
C0205436 (UMLS CUI 2011AA)
81170007 (SNOMED CT 2011_0131)
C0008976 (UMLS CUI 2011AA)
110465008 (SNOMED CT 2011_0131)
C0205171 (UMLS CUI 2011AA)
50607009 (SNOMED CT 2011_0131)
C2699424 (UMLS CUI 2011AA)
C0600558 (UMLS CUI 2011AA)
Consolidation cycle one and two are given according to the accredited study group policy
Item
Consolidation cycle one and two are given according to the accredited study group policy
boolean
C0702116 (UMLS CUI 2011AA)
9656002 (SNOMED CT 2011_0131)
C0439596 (UMLS CUI 2011AA)
44180009 (SNOMED CT 2011_0131)
C0680240 (UMLS CUI 2011AA)
C0008976 (UMLS CUI 2011AA)
110465008 (SNOMED CT 2011_0131)
CL415249 (UMLS CUI 2011AA)
RGRP (HL7 V3 2006_05)
C0242456 (UMLS CUI 2011AA)
No investigational drugs are used post registration for the HCT vs CT in elderly AML study.
Item
No investigational drugs are used post registration for the HCT vs CT in elderly AML study.
boolean
C1518422 (UMLS CUI 2011AA)
C0013230 (UMLS CUI 2011AA)
C0472699 (UMLS CUI 2011AA)
234336002 (SNOMED CT 2011_0131)
C0392920 (UMLS CUI 2011AA)
150415003 (SNOMED CT 2011_0131)
C0001792 (UMLS CUI 2011AA)
105436006 (SNOMED CT 2011_0131)
10014348 (MedDRA 14.1)
C0023467 (UMLS CUI 2011AA)
91861009 (SNOMED CT 2011_0131)
10000880 (MedDRA 14.1)
C92.0 (ICD-10-CM Version 2010)
205.0 (ICD-9-CM Version 2011)
C0008976 (UMLS CUI 2011AA)
110465008 (SNOMED CT 2011_0131)
Documentation for the HCT vs CT in elderly AML study is not compromised. Second hand data from foreign study is not accepted
Item
Documentation for the HCT vs CT in elderly AML study is not compromised. Second hand data from foreign study is not accepted
boolean
C0920316 (UMLS CUI 2011AA)
C0472699 (UMLS CUI 2011AA)
234336002 (SNOMED CT 2011_0131)
C0392920 (UMLS CUI 2011AA)
150415003 (SNOMED CT 2011_0131)
C0001792 (UMLS CUI 2011AA)
105436006 (SNOMED CT 2011_0131)
10014348 (MedDRA 14.1)
C0023467 (UMLS CUI 2011AA)
91861009 (SNOMED CT 2011_0131)
10000880 (MedDRA 14.1)
C92.0 (ICD-10-CM Version 2010)
205.0 (ICD-9-CM Version 2011)
C0008976 (UMLS CUI 2011AA)
110465008 (SNOMED CT 2011_0131)
C1518422 (UMLS CUI 2011AA)
C0221099 (UMLS CUI 2011AA)
260379002 (SNOMED CT 2011_0131)

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial